A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Guo / guanosine

[Related PubMed/MEDLINE]
Total Number of Papers: 91
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Guo  (>> Co-occurring Abbreviation)
Long Form:   guanosine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model. IMI, MDD
2021 Effects of intranasal guanosine administration on brain function in a rat model of ischemic stroke. In-Guo
2021 Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms. PNP
2021 Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy. PI3K
2020 Guanosine enhances glutamate uptake and oxidation, preventing oxidative stress in mouse hippocampal slices submitted to high glutamate levels. Glu
2020 Guanosine protects against behavioural and mitochondrial bioenergetic alterations after mild traumatic brain injury. ETS, OXPHOS, RCR, TBI
2020 Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A1 and A2A Receptors. ADO, ARs
2020 Identification of guanine, guanosine, and inosine for alpha-amylase inhibitors in the extracts of the earthworm Eisenia fetida and characterization of their inhibitory activities against porcine pancreatic alpha-amylase. Gua, Ino, PPA, SPE
2020 Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice. PD, ROS, TJMs
10  2019 A1 rather than A2A adenosine receptor as a possible target of Guanosine effects on mitochondrial dysfunction following Traumatic Brain Injury in rats. CNS, FPI, TBI
11  2019 Amino acid-linked platinum(II) compounds: non-canonical nucleoside preferences and influence on glycosidic bond stabilities. AAPt, ADO, CisPt, dAdo, dGuo
12  2019 Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors. CaMKII, ERK, GBPs, GMP, GMP, NMDA, PI3K, PKA, PKC
13  2019 Guanosine Prevents against Glutamatergic Excitotoxicity in C. elegans. WT
14  2019 Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine. DLS, PD, PFC
15  2019 Guanosine protects against Ca2+-induced mitochondrial dysfunction in rats. ---
16  2019 Long lasting behavioral and electrophysiological action of early administration of guanosine: Analysis in the adult rat brain. CSD, EPM
17  2018 Guanosine Attenuates Behavioral Deficits After Traumatic Brain Injury by Modulation of Adenosinergic Receptors. TBI
18  2018 Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion. PD, ROS
19  2018 Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats. ---
20  2018 New gold pincer-type complexes: synthesis, characterization, DNA binding studies and cytotoxicity. 5'-GMP, CT-DNA, Me2LtBu, 2, ROS
21  2018 Uncovering the Signaling Pathway behind Extracellular Guanine-Induced Activation of NO System: New Perspectives in Memory-Related Disorders. GDA, Gua, PNP
22  2017 Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. PD
23  2017 Delayed administration of guanosine improves long‑term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke. BDNF, BrdU, NeuN, VEGF
24  2017 Gas-Phase Conformations and N-Glycosidic Bond Stabilities of Sodium Cationized 2'-Deoxyguanosine and Guanosine: Sodium Cations Preferentially Bind to the Guanine Residue. dGuo, ER-CID, IRMPD
25  2017 Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells. TMZ
26  2016 Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication. CSF, EEG, i.p
27  2016 Guanosine may increase absence epileptic activity by means of A2A adenosine receptors in Wistar Albino Glaxo Rijswijk rats. A2AR, ADO, i.p, LPS, QA, SWDs
28  2016 Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation. GS, OGD
29  2016 Regulation of Mitochondrial Function and Glutamatergic System Are the Target of Guanosine Effect in Traumatic Brain Injury. FPI, TBI
30  2015 Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats. a,d, ADO, CNS, GABAA receptors, i.p, Ino, NMDA, non-Ado, PTZ, QA, SWDs, Urd
31  2015 Effects of nucleosides on glia - neuron interactions open up new vistas in the development of more effective antiepileptic drugs. ADO, CNS, Ino, Urd
32  2015 Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats. ---
33  2015 Modulatory effects of inosine, guanosine and uridine on lipopolysaccharide-evoked increase in spike-wave discharge activity in Wistar Albino Glaxo/Rijswijk rats. i.p, Ino, LPS, non-Ado, SWDs, Urd
34  2014 Guanosine protects glial cells against 6-hydroxydopamine toxicity. DA, PD
35  2014 Non-adenosine nucleoside inosine, guanosine and uridine as promising antiepileptic drugs: a summary of current literature. ADO, CNS, Ino, non-Ado, Urd
36  2014 Total inhibition of (1)O2-induced oxidative damage to guanine bases of DNA/RNA by turmeric extracts. ---
37  2013 5'-nucleotidases, nucleosides and their distribution in the brain: pathological and therapeutic implications. ADO, CNS, Ino, Urd
38  2013 G-quadruplex guanosine gels and single walled carbon nanotubes. G-gels, GMP, SWNTs
39  2013 Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. A2AR, OGD
40  2013 The antiepileptic potential of nucleosides. ADK, ADO, Ino, non-Ado, Urd
41  2012 Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid. QA, ROS, TBARS
42  2012 Efficient determination of purine metabolites in brain tissue and serum by high-performance liquid chromatography with electrochemical and UV detection. ADO, Gua, HPLC, Hyp, Ino, LOD, UA, Xan
43  2012 Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 5'-GMP, 9MeG
44  2012 Guanosine protects against reperfusion injury in rat brains after ischemic stroke. ER, IL-8, MCAO, OGD, ROS
45  2012 Supramolecular arrangement of guanosine/5-guanosine monophosphate binary mixtures studied by methods of circular dichroism. GMP
46  2011 Alkylating potential of alpha,beta-unsaturated compounds. AA, AC, alpha,beta-UC, AM, AN
47  2011 Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion. BDNF, CSF
48  2011 Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. ER, MCAO
49  2010 Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. AD
50  2009 Analysis of an RNA adduct formed from aminophenylnorharman. ---
51  2009 Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine. DRF, i.p, Ino, MN
52  2009 Quantitative determination of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxo-7,8-dihydroguanine, 8-oxo-7,8-dihydroguanosine, and their non-oxidized forms: daily concentration profile in healthy volunteers. 8-oxodGuo, 8-oxoGua, 8-oxoGuo, dGuo, Gua
53  2009 The effect of preservation solutions UW and EC on purine concentration in rat kidney. ADO, ADP, AMP, ATP, EC, GMP, HPLC, Hyp, IMP, Ino, TAN, UW, Xan
54  2008 Cyclic tetranuclear half-sandwich ruthenium(II) complexes with 4,7-phenanthroline and hydroxo bridges: crystal structure, solution behaviour and binding to nucleosides. Cyt, dAdo, phen
55  2008 Extracellular guanosine and GTP promote expression of differentiation markers and induce S-phase cell-cycle arrest in human SH-SY5Y neuroblastoma cells. GTP
56  2008 Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway. PKC, PLC
57  2008 Importance of schedule of administration in the therapeutic efficacy of guanosine: early intervention after injury enhances glutamate uptake in model of hypoxia-ischemia. HI
58  2008 Neurotrophic effects of extracellular guanosine. CNS, ecto-PNP, eGUA
59  2008 Tunable thermoassociation of binary guanosine gels. CD, GMP
60  2007 Guanine derivatives modulate extracellular matrix proteins organization and improve neuron-astrocyte co-culture. ECM, GD, GMP, MAPK, PKA, PKC
61  2007 Oxypurine and purine nucleoside concentrations in renal vein of allograft are potential markers of energy status of renal tissue. AMP, ATP, HPLC, Hyp, Ino, UA, Urd, Xan
62  2007 Role of ionization of the phosphate cosubstrate on phosphorolysis by purine nucleoside phosphorylase (PNP) of bacterial (E. coli) and mammalian (human) origin. Ino, PNP
63  2006 Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells. LC-MS, MS, ONE
64  2006 Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. ADO, ADP, AEC, AMP, ATP, GDP, GMP, GTP, Hyp, IMP, Ino, NAD, NADP, TAN, TMZ, UA, Urd, Xan
65  2006 GTP induces S-phase cell-cycle arrest and inhibits DNA synthesis in K562 cells but not in normal human peripheral lymphocytes. GPA, GTP, PBL
66  2006 Guanosine promotes the up-regulation of inward rectifier potassium current mediated by Kir4.1 in cultured rat cortical astrocytes. ---
67  2005 Chromatographic separation of nucleosides using a cross-linked xylose isomerase crystal stationary phase. ADO, Cyd, Urd
68  2005 Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. HI
69  2004 Anticonvulsant effect of GMP depends on its conversion to guanosine. CSF, GMP, i.p, QA
70  2004 Effect of lead ions on rat erythrocyte purine content. ATP, ADP, and AMP, HPLC, Hyp, IMP, Ino
71  2004 Formamidopyrimidines as major products in the low- and high-intensity UV irradiation of guanine derivatives. ---
72  2003 Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. ---
73  2002 Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. 5'-GMP
74  2002 Potentiating effect of mizoribine on the anti-herpes virus activity of acyclovir. ACV, dNTP, HESMF, HSV-1, MZR
75  2002 Purine nucleoside phosphorylase from Cellulomonas sp.: physicochemical properties and binding of substrates determined by ligand-dependent enhancement of enzyme intrinsic fluorescence, and by protective effects of ligands on thermal inactivation of the enzyme. Gua, HX, Ino, PNP, R1P
76  2002 Xanthosine and xanthine. Substrate properties with purine nucleoside phosphorylases, and relevance to other enzyme systems. Gua, HX, Ino, PNP, Xan, Xao
77  2001 Separation of inosine, hypoxanthine, and guanosine by high-performance liquid chromatography on silica. Hyp, Ino
78  2000 Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. ADA, ADO, EHNA
79  2000 Mechanism of formation of guanine as one of the major products in the 254 nm photolysis of guanine derivatives: concentration and pH effects. dGuo, GMP, Gua
80  2000 Photochemical and photophysical studies of guanine derivatives: intermediates contributing to its photodestruction mechanism in aqueous solution and the participation of the electron adduct. Gua
81  1997 Mechanism and intermediate for formation of 2'-deoxyoxanosine. 1-MeGuo, dGuo, dOxo, NO, Oxo, RP, Xao
82  1994 Epitope complementarity and idiotypic interactions: a study of idiotypic-like interactions between anti-cytidine and anti-guanosine A/J mouse monoclonal antibodies--I. Characterization of these interactions. Cyd
83  1993 Optimized separation of purine bases and nucleosides in human cord plasma by capillary zone electrophoresis. Ade, ADO, Gua, Hyp, Ino, UA, Xan
84  1992 Relaxation kinetics of ribonuclease T1 binding with guanosine and 3'-GMP. eq, RNase T1
85  1992 Substitution of p- and o-hydroxyphenyl radicals at the 8 position of purine nucleosides by reaction with mutagenic p- and o-diazoquinones. dAdo, dGuo
86  1990 Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency. dGTP, dGuo, PNP
87  1988 Reaction of trans-4-N-acetoxy-N-acetylaminostilbene with guanosine and deoxyguanosine in vitro: the primary reaction product at N2 of guanine yields different final adducts. dGuo, Gua, N-acetoxy-AAS
88  1986 Aminations of guanosine and deoxyguanosine with hydroxylamine-O-sulfonic acid and 2,4-dinitrophenoxyamine. Dependence on the reaction medium. dG
89  1984 Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia. FdUrd, FUra, FUrd
90  1984 Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo. dGuo, DTH, GVH, HVG, s.c
91  1976 Ribose recognition by ribonuclease T1: difference spectral binding studies with guanosine and deoxyguanosine. dGuo